Xencor (XNCR) Other Working Capital Changes (2013 - 2026)
Xencor (XNCR) posted quarterly Other Working Capital Changes of $2.4 million for Q1 2026, up 750.0% year-over-year from $281411.8 in Q1 2025, and up 116.27% quarter-over-quarter from $1.1 million in Q4 2025.
Xencor (XNCR) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Other Working Capital Changes for 9 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 750.0% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $9.9 million (up 2800.27% YoY), while the FY2025 annual figure was $7.2 million, changed N/A from the prior year.
- Other Working Capital Changes climbed to $2.4 million in Q1 2026 per XNCR's latest filing, from $1.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $6.9 million in Q2 2024 and bottomed at -$5.3 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged -$774823.5 across 5 years, with a median of -$680000.0 in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 1300.88% in 2023 and fell as far as 11666.67% in 2023.
- Xencor's Other Working Capital Changes stood at -$4.9 million in 2022, then tumbled by 89.52% to -$9.2 million in 2023, then soared by 36.1% to -$5.9 million in 2024, then surged by 118.77% to $1.1 million in 2025, then jumped by 116.27% to $2.4 million in 2026.
- Business Quant data shows XNCR's Other Working Capital Changes at $2.4 million in Q1 2026, $1.1 million in Q4 2025, and -$216000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Xencor | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -738,000.00 |
| Jun 30, 2026 | -738,000.00 |
| Jun 30, 2026 | -738,000.00 |
| Mar 31, 2026 | 2.17 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Mar 31, 2026 | 2.17 Mn |
| Dec 31, 2025 | -680,000.00 |
| Dec 31, 2025 | -680,000.00 |
| Dec 31, 2025 | -680,000.00 |
| Sep 30, 2025 | -5.26 Mn |
| Sep 30, 2025 | -5.26 Mn |
| Sep 30, 2025 | -5.26 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Dec 31, 2024 | 169,000.00 |
| Dec 31, 2024 | 169,000.00 |